CD44 and gastric cancer: In gastric cancer, ablation of a CD44 variant (CD44v) diminishes membrane xCT and suppresses tumor growth accompanied by a greater expression of phospho-p38 MAPK and upregulation of p21 in the cancer cells that adopt a more differentiated and less proliferative state (230).